. Author manuscript; available in PMC: 2020 Dec 18.

Published in final edited form as: J Pathol. 2020 May 18;251(3):284–296. doi: 10.1002/path.5451

Table 1.

Tumor spectrum and burden in WT, Trp73^+/−, Fdxr^+/− and Trp73^+/−;Fdxr^+/− mice

Tumor	WT (n = 51)^*	Trp73^+/− (n = 26)^*	Fdxr^+/− (n = 29)^*	Trp73^+/−;Fdxr^+/− (n = 20)^*
DLBCL	6	3	12	4
T-LBL	2	1	5	0
Unclassified LM	3	6	2	0
Sarcoma	1	1	7	0
Adenoma	0	1	2	0
Hemangioma	0	1	3	0
Hepatoma	0	1	0	0
Lung adenocarcinoma	0	0	4	0
HCC	0	0	2	0
Plasmacytoma	0	0	1	0
Tumor penetrance	11/51	12/26	26/29	4/20

DLBCL, diffuse large B-cell lymphoma; T-LBL, thymic lymphoblastic lymphoma; HCC, hepatocellular carcinoma; LM, lymphoma.

Dead/hydrocephalus mice were excluded.